Bo H. Chao
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 8
- Colorectal Cancer Treatments and Studies 7
- Lung Cancer Research Studies 4
-
- Lung Cancer Treatments and Mutations 23
- Lung Cancer Diagnosis and Treatment 11
- Renal cell carcinoma treatment 2
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 10
-
- Ubiquitin and proteasome pathways 3
- Co-authors
- Leena GandhiMark A. SocinskiSai‐Hong Ignatius OuD. Ross CamidgeHossein BorghaeiShirish M. GadgeelBogdana BalasAlberto Chiappori
- Partner nations
- United StatesFranceChina
In The Last Decade
Bo H. Chao
47 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 872
- Pulmonary and Respiratory Medicine 833
- Cancer Research 205
- Immunology 132
- Molecular Biology 375
Countries citing papers authored by Bo H. Chao
This map shows the geographic impact of Bo H. Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo H. Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo H. Chao more than expected).
Fields of papers citing papers by Bo H. Chao
This network shows the impact of papers produced by Bo H. Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo H. Chao. The network helps show where Bo H. Chao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bo H. Chao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 3 | |
| 5 | 2021 | 4 | |
| 6 | 2021 | 10 | |
| 7 | 2020 | 31 | |
| 8 | 2020 | 36 | |
| 9 | 2020 | 44 | |
| 10 | 2020 | 19 | |
| 11 | 2018 | 114 | |
| 12 | 2018 | 2 | |
| 13 | 2017 | 10 | |
| 14 | 2016 | 14 | |
| 15 | 2016 | 55 | |
| 16 | Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trialbreakdown → | 2015 | 462 |
| 17 | 2010 | 10 | |
| 18 | 2009 | 9 | |
| 19 | 2007 | 12 | |
| 20 | 2004 | 43 |
About Bo H. Chao
Bo H. Chao is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 49 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Diagnosis and Treatment (11 papers), Cancer Genomics and Diagnostics (10 papers), Cancer Immunotherapy and Biomarkers (8 papers), Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Research Studies (4 papers), Ubiquitin and proteasome pathways (3 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Oncology (872 citations), Pulmonary and Respiratory Medicine (833 citations) and Cancer Research (205 citations). Bo H. Chao has collaborated with scholars based in United States, France and China. Frequent co-authors include Leena Gandhi, Mark A. Socinski, Sai‐Hong Ignatius Ou, D. Ross Camidge, Hossein Borghaei, Shirish M. Gadgeel, Bogdana Balas, Alberto Chiappori, Tarek Mekhail and Gregory J. Riely.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.